Skip to main content
HighlightsHighlights Archive

Media Monitoring: 2 – 8 May

New blood test shows promise in early detection of ovarian cancer Epithelial ovarian cancer (EOC) accounts for the most significant number of deaths from female reproductive system cancers. A new paper published in the British Journal of Cancer explores the potential utility of glycoproteins as biomarkers of EOC. In the future, these types of models might allow the diagnosis of…
Ben Kemp
May 7, 2024
HighlightsHighlights Archive

New screening trial to save thousands of men’s lives from prostate cancer

Thousands more men could be saved every year as a new screening trial aims to double the efficacy of prostate cancer screening. The £42m trial called TRANSFORM aims to find the best way to screen men for prostate cancer and is co-funded by Prostate Cancer UK and NIHR. The Government is investing £16m for the trial through NIHR. Movember is providing £1.5m funding, and…
Ben Kemp
May 7, 2024
HighlightsHighlights Archive

ONS says UK R&D may be worth far more than currently estimated

Early findings from a revamped Office for National Statistics survey published suggest that the value of research and development undertaken in Britain each year could be more than 20% higher than estimates currently show. According to the redeveloped Business Enterprise Research and Development Survey, R&D expenditure in 2022 amounted to £53 billion pounds, compared with an existing estimate of £43.4 billion pounds…
Ben Kemp
May 7, 2024
HighlightsHighlights Archive

Media Monitoring: April 25 – May 1

Virtual wards: We are in danger of being eclipsed by our European neighbours Great progress has been made in extending virtual wards across the NHS in England. It is leading the way on virtual ward provision. However, there is a risk of being eclipsed by other European countries on the use of remote monitoring for wider health care. We can…
Ben Kemp
April 29, 2024
HighlightsHighlights Archive

Study highlights increased risk of second cancers among breast cancer survivors

Survivors of breast cancer are at significantly higher risk of developing second cancers, including endometrial and ovarian cancer for women and prostate cancer for men, according to new research studying data from almost 600,000 patients in England. For the first time, the research has shown that this risk is higher in people living in areas of greater socioeconomic deprivation. Breast…
Ben Kemp
April 29, 2024
HighlightsHighlights Archive

HDR UK and GA4GH form a strategic partnership to unite genomic and health data

Health Data Research UK (HDR UK), the UK's national institute for health data science, and the Global Alliance for Genomics and Health (GA4GH) have announced a strategic partnership to expand existing open standards work and collaborate in the wider health data space. Together, both organisations plan to learn from global partners and promote adoption of health data related standards around the…
Ben Kemp
April 29, 2024
HighlightsHighlights Archive

Media Monitoring: 18 – 24 April

Women’s health hubs The recently published 2024/25 operational planning guidance asks ICBs to “establish and develop at least one women’s health hub in every ICB by the end of December 2024 in line with the core specification. It sets the expectation that at least 75% of ICBs have a hub in place by July 2024 that meets minimum requirements. The…
Ben Kemp
April 23, 2024
HighlightsHighlights Archive

New £10.4M rare kidney disease research centre to pioneer new tests treatments

Thousands of people living with rare kidney disease will get access to improved diagnostics, treatments and potentially cures, thanks to the creation of a new research centre co-funded by Kidney Research UK and medical charity LifeArc. It will be led by experts from Alder Hey Children’s NHS Foundation Trust and the University of Liverpool. The LifeArc-Kidney Research UK Centre for Rare…
Ben Kemp
April 23, 2024
HighlightsHighlights Archive

Genomics in Scotland: Building our Future strategy released

The Scottish Government have released their 'Genomics in Scotland: Building our Future strategy', which establishes their commitment to the development of a robust and sustainable national genomic medicine service. The initial implementation plan will focus on the foundational and preparatory work needed, in collaboration with stakeholders across Scotland, to ensure that investment and partnership working is targeted to benefit those that…
Ben Kemp
April 23, 2024
HighlightsHighlights Archive

Media Monitoring: 11 – 17 April

Diagnostic checks rolled out to 160 sites under CDC programme Patients can now benefit from vital tests, checks and scans being delivered at 160 sites across England as part of the CDC programme. Latest statistics show sites have already delivered more than 7 million tests, checks and scans across England.   Labour vows to fund NHS pledges by tackling tax…
Ben Kemp
April 17, 2024